GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ND5) » Definitions » Net Interest Income (for Banks)

H. Lundbeck AS (LTS:0ND5) Net Interest Income (for Banks)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


H. Lundbeck AS (LTS:0ND5) Business Description

Industry
Address
Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.